Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat and Pembrolizumab in Advanced/Metastatic Sarcoma
NCT03414229Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in sarcoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Jan 2018; status: active, not recruiting.
02
Drugs
epacadostat
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT03414229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414229.